Skip to main content
. 2025 Mar 20;17(6):1037. doi: 10.3390/cancers17061037
AP Anterior prostate
AR Androgen receptor
ATM Ataxia-telangiectasia mutated
B2m Beta-2-microglobulin
BSA Bovine serum albumin
BSB Basis staining buffer
Cdh1 E-cadherin
CDKN1a Cyclin-dependent kinase inhibitor 1A
Cre Cyclization recombinase
DAB 3,3′-Diaminobenzidine
DAPI 4′,6-diamidino-2-phenylindole
DLP Dorsolateral prostate
DMSO Dimethyl sulfoxide
dPCR Digital polymerase chain reaction
EDTA Ethylenediaminetetraacetic acid
EGTA Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid
EMT Epithelial mesenchymal transition
FLP Flippase
FRT Flippase recognition target
HAT Histone acetyltransferase
HRP Horseradish peroxidase
IHC Immunohistochemistry
ING3 Inhibitor of growth 3
lacZ β-galactosidase gene
LoxP Locus of X-over P1
mRNA Messenger RNA
NBS1 Nibrin
NuA4 Nucleosome acetyltransferase of histone H4
PB Probasin
PBS Phosphate-buffered saline
PCR Polymerase chain reaction
PHD
PIN
Plant homeodomain
Prostatic intraepithelial neoplasia
Pten Phosphatase and tensin homologue
SPB Sodium phosphate buffer
TBST Tris-buffered saline with Tween 20
VP Ventral prostate
X-gal 5-Bromo-4-chloro-3-indolyl β-D-galactopyranoside